MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Country |
 USA |
IPO year |
1986 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
43.6 M |
Market Cap[1] |
$ 1.49 B |
EBITDA (LTM) |
$ 52.9 M |
P/E (LTM) |
- |
P/S (LTM) |
4.65 |
EPS (LTM) |
0.6 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Brainsway Ltd.
BWAY
|
$ 23.08 | 1.7 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
$ 29.14 | -3.75 % | $ 326 M | Nasdaq Global Market |  China |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.1 | 0.46 % | $ 1.4 M | Nasdaq Capital Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 11.38 | 1.16 % | $ 323 M | Nasdaq Capital Market | Israel |
 |
DexCom
DXCM
|
$ 70.29 | 8.0 % | $ 27.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 103.65 | -1.16 % | $ 4.09 B | Nasdaq Global Select Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 32.89 | 3.09 % | $ 914 M | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 211.14 | -1.74 % | $ 154 B | NYSE,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 205.13 | -0.82 % | $ 22.8 B | NYSE,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Fulgent Genetics
FLGT
|
$ 23.24 | 1.18 % | $ 703 M | Nasdaq Global Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
CareDx, Inc
CDNA
|
$ 19.6 | 2.62 % | $ 1.05 B | Nasdaq Global Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.85 | - | $ 8.12 M | Nasdaq Global Select Market | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.32 | 0.09 % | $ 19.1 B | Nasdaq Capital Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 68.71 | -0.02 % | $ 4.75 B | Nasdaq Global Select Market,SPB | USA |
 |
Guardant Health
GH
|
$ 104.76 | 1.95 % | $ 12.9 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
National Research Corporation
NRC
|
$ 12.09 | -5.81 % | $ 297 M | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 160.2 | 0.91 % | $ 8.23 B | NYSE,SPB | USA |
 |
IDEXX Laboratories
IDXX
|
$ 627.58 | 1.68 % | $ 51.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 115.9 | 1.27 % | $ 18.4 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.24 | 2.48 % | $ 861 M | Nasdaq Global Select Market | USA |
 |
IQVIA Holdings
IQV
|
$ 166.72 | -1.27 % | $ 30.2 B | NYSE,SPB | USA |
 |
Natera
NTRA
|
$ 204.66 | -1.53 % | $ 20.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 31.11 | -0.94 % | $ 20 B | NYSE | Niderland |
|
Biodesix
BDSX
|
$ 11.55 | 6.6 % | $ 1.5 B | Nasdaq Global Market | USA |
 |
Personalis
PSNL
|
$ 8.22 | -2.09 % | $ 487 M | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 281.39 | 1.13 % | $ 23.6 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 95.34 | 19.06 % | $ 7.86 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Quidel Corporation
QDEL
|
$ 23.61 | -0.55 % | $ 995 M | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.25 | 4.19 % | $ 5.17 M | Nasdaq Capital Market | USA |
 |
Bioventus
BVS
|
$ 8.22 | 1.48 % | $ 515 M | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 429.09 | 3.14 % | $ 12.4 B | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.